Cube Highways Trust Regulatory Approval

Financial Results

Cube Highways Trust Q2 FY27 Results: Net Profit ₹8 Cr, Down 80.1% YoY

Cube Highways Trust reported revenue from operations of ₹1,074 Cr (+2.1% YoY) and net profit of ₹8 Cr (-80.1% YoY) for Q2 FY27.

Key figure

Net profit ₹8 Cr · -80.1% YoY

Financial Results

Cube Highways Trust Q1 FY27 Results: Net Profit ₹61.1 Cr, Up 12120.0% YoY

Cube Highways Trust reported revenue from operations of ₹1,127 Cr (+19.3% YoY) and net profit of ₹61.1 Cr (+12120.0% YoY) for Q1 FY27.

Key figure

Net profit ₹61.1 Cr · +12120.0% YoY

Board Meeting Date

Cube Highways Trust Board Meeting Date

Cube Highways Trust will hold a board meeting on August 14, 2026, to consider quarterly financial results, potential distributions, and new debt financing plans.

Promoter Selling

Cube Highways Trust Promoter Selling: ₹2,342 Cr

Sponsor Group entities sold units worth ₹2,342.36 Crore via Offer for Sale (OFS) in Cube Highways Trust, reducing their aggregate unitholding.

Value

₹2,342 Cr

Other Announcement

Cube Highways Trust Other Announcement

Cube Highways Trust submitted its unitholding pattern as of July 31, 2026, following the trust's conversion from a private to a public InvIT via OFS.

Capital Structure Change

Cube Highways Trust Capital Structure Change

Cube Highways Trust has received approval to convert from a privately listed to a publicly listed InvIT, effective July 31, 2026. This facilitates public trading.

Regulatory ApprovalShalby Ltd SHALBYAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Shalby Regulatory Approval

Shalby Hospital, Jabalpur received CMHO permission to resume normal operations, including patient admissions, on its previously affected floor. The hospital has now fully resumed healthcare services.

Regulatory ApprovalElantas Beck India Ltd ELANTASAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Elantas Beck India Regulatory Approval

Elantas Beck India's GPCB permanently revoked the closure direction on its Ankleshwar plant. The facility can keep operating, subject to compliance conditions.

Regulatory ApprovalKalyani Cast-Tech Ltd 544023Alfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Kalyani Cast-Tech Regulatory Approval

Kalyani Cast-Tech received RDSO Stage-I concept design approval for its new container-carrying wagon under PWDA. Stage-II detailed design approval is still required, subject to dynamics simulation conditions.

Regulatory ApprovalMukka Proteins Ltd MUKKAAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Mukka Proteins Regulatory Approval

Mukka Proteins received a US FDA facility registration certificate, valid October 1, 2026 to December 31, 2027. The company says the registration supports its engagement with US customers and markets.

Execution

October 1, 2026 to December 31, 2027

Regulatory ApprovalCanara Bank CANBKAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Canara Bank Regulatory Approval

Canara Bank received RBI permission to exercise the call option on its Basel III AT1 bonds (ISIN INE476A08134) of Rs.1,500 Crore. The bank is now in process of exercising the call as per the issue terms.

Value

₹1,500 Cr

Regulatory ApprovalAlembic Pharmaceuticals Ltd APLLTDAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Alembic Pharmaceuticals Regulatory Approval

Alembic Pharmaceuticals received USFDA final approval for Valganciclovir for Oral Solution, 50 mg/mL. This adds to its cumulative 247 USFDA ANDA approvals.